Idiopathic pulmonary fibrosis trials in Finland
4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in FinlandA Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment
- Where
- Helsinki, Tampere, Turku
- Age
- 40 years and over
- People
- 70 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07926321 · EU 2026-527098-13-00 - Phase 3Not yet taking people in FinlandLong-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
- Where
- Helsinki, Turku
- Age
- 18 years and over
- People
- 2,380 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Idiopathic Pulmonary Fibrosis
- Where
- Helsinki, Turku
- Age
- 18 years and over
- People
- 239 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503697-21-01 · EU 2023-503697-21-01 - Phase 3Taking peopleA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis
- Where
- Helsinki, Turku
- Age
- 18 years and over
- People
- 249 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2023-503699-25-00 · EU 2023-503699-25-00